We have gained prominence for providing high-quality Polymyxin B Injections in the global market. Made as per medical standards, our Polymyxin B Injections are quality-proven and feature long shelf stability.

Description :

• Polymyxin B  Injection 500000 Units  is a drug of choice in the treatment of infections of the urinary tract, meninges, and bloodstream caused by susceptible strains of Ps. aeruginosa. It may also be used topically and subconjunctivally in the treatment of infections of the eye caused by susceptible strains of Ps. aeruginosa.It may be indicated in serious infections caused by susceptible strains of the following organisms, when less potentially toxic drugs are ineffective or contraindicated: H influenzae, specifically meningeal infections. Escherichia coli, specifically urinary tract infections. Aerobacter aerogenes, specifically bacteremia . Klebsiella pneumoniae, specifically bacteremia.
• 3s corporation is Supplier,Exporter ,Wholesaler  for Polymyxin B  Injection 500000 Units in India.
• We even  offer contract manufacturing services from WHO GMP approved factories.

Additional Information :

• Intravenous - Dissolve 500,000 polymyxin B (polymyxin b sulfate) units in 300 to 500 mL solutions for parenteral dextrose injection 5% for continuous drip.
• Adults and children - 15,000 to 25,000 units/kg body weight/day in individuals with normal kidney function.This amount should be reduced from 15,000 units/kg downward for individuals with kidney impairment. Infusions may be given every 12 hours; however, the total daily dose must not exceed 25,000 units/kg/day.
• Infants - Infants with normal kidney function may receive up to 40,000 units/kg/day without adverse effects.
• Intramuscular - Not recommended routinely because of severe pain at injection sites, particularly in infants and children. Dissolve 500,000 polymyxin B units in 2 mL sterile water for injection or sodium chloride injection or procaine hydrochloride injection 1%.
• Adults and children - 25,000 to 30,000 units/kg/day.This should be reduced in the presence of renal impairment.The dosage may be divided and given at either 4 or 6 hour intervals.
• Infants - Infants with normal kidney function may receive up to 40,000 units/kg/day without adverse effects.

Side Effects :

• Ephrotoxic reactions - Albuminuria, cylin-duria,azotemia, and rising blood levels without any increase in dosage.
• Neurotoxic reactions -  Facial flushing, dizziness progressing to ataxia, drowsiness, peripheral paresthesias (circumoral and stocking glove), apnea due to concurrent use of curariform muscle relaxants, other neurotoxic drugs or inadvertent overdosage, and signs of meningeal irritation with intrathecal administration, e.g., fever, headache, stiff neck and increased cell count and protein cerebrospinal fluid.
• Other reactions occasionally reported - Drug fever, urticarial rash, pain (severe) at intramuscular injection sites, and thrombophlebitis at intravenous injection sites.